Medscape
TOPLINE: The administration of the human papillomavirus nonavalent (9vHPV) vaccine after a surgical treatment for low- and high-grade cervical intraepithelial neoplasia resulted in a significant reduction in the proportion of women positive for HPV over the 15-month study period. METHODOLOGY: Researchers conducted a retrospective study to examine the effectiveness of the 9vHPV vaccine after surgical …
Read More
HPV Vaccine Post-Surgery Cuts Viral Persistence
Tama Catt
06:20
TOPLINE: The administration of the human papillomavirus nonavalent (9vHPV) vaccine after a surgical treatment for low- and high-grade cervical intraepithelial neoplasia resulted in a significant reduction in the proportion of women positive for HPV over the 15-month study period. METHODOLOGY: Researchers conducted a retrospective study to examine the effectiveness of the 9vHPV vaccine after surgical
